CompaniesElpen Pharmaceutical

Elpen Pharmaceutical

active

Athens, Greece

Founded 1965

Website

About

Small Molecules, Generics

Areas of Focus

Categories

Generic DrugOther European

Clinical Trials (45)

View all

Total Trials

As Lead Sponsor

As Collaborator

Total Enrollment

31,166

By Phase

PHASE2: 1PHASE2/PHASE3: 1PHASE3: 2PHASE4: 1NA: 1

By Status

COMPLETED: 30WITHDRAWN: 7RECRUITING: 3UNKNOWN: 3NOT_YET_RECRUITING: 2

Clinical Trials Pipeline45 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Today

NCT01484210

Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus®

Phase: Phase 3

Role: Lead Sponsor

Start: Mar 31, 2008

Completion: Oct 31, 2008

NCT05459194

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2008

Completion: Jan 31, 2009

NCT01484327

Carvedilol Vascular Efficacy Trial

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2009

Completion: Nov 30, 2011

NCT01475045

ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment)

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2011

Completion: Sep 30, 2011

NCT01677637

Osteoporosis Screening Trial

Phase: N/A

Role: Lead Sponsor

Start: Feb 29, 2012

Completion: Jul 31, 2014

NCT01708486

BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) Study

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2013

Completion: Jun 30, 2014

NCT01770210

Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2013

Completion: Jul 31, 2014

NCT01772095

ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2013

Completion: Nov 30, 2013

NCT01800994

Prospective evAluatIon foR Inhalation Devices Study

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2013

Completion: Dec 31, 2013

NCT01855659

A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method.

Phase: N/A

Role: Lead Sponsor

Start: Jun 30, 2013

Completion: Nov 30, 2013

NCT02006862

eVAluatIon of OLanzapine TreatmEnT

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2014

Completion: Dec 31, 2014

NCT02051361

Antiplatelet Therapy Following Stent Implantation

Phase: N/A

Role: Lead Sponsor

Start: Apr 30, 2014

Completion: May 31, 2016

NCT01991093

Multiple Electrode Aggregometry & Clopidogrel Resistance

Phase: N/A

Role: Lead Sponsor

Start: Jun 30, 2014

Completion: Jan 31, 2015

NCT02148991

Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2014

Completion: Jan 31, 2017

NCT02344199

Eplerenone in Heart Failure Treatment

Phase: N/A

Role: Lead Sponsor

Start: Mar 31, 2015

Completion: Apr 30, 2016

NCT02356731

LevetIracetam in Patients Being Treated for Epilepsy

Phase: N/A

Role: Lead Sponsor

Start: Mar 31, 2015

Completion: Dec 31, 2016

NCT02392416

Atorvastatin Study in Cardiovascular Disease Risk

Phase: N/A

Role: Lead Sponsor

Start: Apr 30, 2015

Completion: Feb 29, 2016

NCT02798055

Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2016

Completion: Jun 30, 2019

NCT02959255

10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection

Phase: Phase 4

Role: Lead Sponsor

Start: Jan 30, 2017

Completion: Dec 30, 2017

NCT02614521

Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2017

Completion: Feb 28, 2019

NCT02978703

EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in Greece

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2017

Completion: Dec 31, 2018

NCT03033758

Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice.

Phase: N/A

Role: Lead Sponsor

Start: Feb 2, 2017

Completion: Dec 30, 2017

NCT03055793

Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical Practice

Phase: N/A

Role: Lead Sponsor

Start: Mar 1, 2017

Completion: Jul 31, 2017

NCT03139084

Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension

Phase: N/A

Role: Lead Sponsor

Start: Dec 1, 2017

Completion: Dec 1, 2019

NCT03299673

AdHerencE to Treatment and quAlity of Life in COPD

Phase: N/A

Role: Lead Sponsor

Start: Dec 1, 2017

Completion: Dec 5, 2018

NCT02582190

COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF

Phase: Phase 3

Role: Lead Sponsor

Start: Dec 2, 2017

Completion: Sep 2, 2018

NCT03300076

COMPLliancE and qualiTy of lifE in Asthma

Phase: N/A

Role: Lead Sponsor

Start: Feb 1, 2018

Completion: Dec 1, 2018

NCT03329729

PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT

Phase: N/A

Role: Lead Sponsor

Start: Feb 1, 2018

Completion: Jan 30, 2019

NCT03317262

Prospective Study of the Evaluation of Disease contRol and the Quality of Life of Patients With depressiOn and With or Without aNxiety disOrders in the Greek populatIon

Phase: N/A

Role: Lead Sponsor

Start: Mar 1, 2018

Completion: Mar 1, 2019

NCT03162120

Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation

Phase: Phase 2/3

Role: Lead Sponsor

Start: Sep 1, 2018

Completion: Dec 1, 2018

NCT03858348

A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination

Phase: N/A

Role: Lead Sponsor

Start: May 1, 2019

Completion: Dec 31, 2019

NCT03947853

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure

Phase: N/A

Role: Lead Sponsor

Start: Oct 1, 2019

Completion: Jan 31, 2020

NCT04835961

AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice.

Phase: N/A

Role: Lead Sponsor

Start: May 1, 2021

Completion: Jul 1, 2022

NCT04902183

Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19

Phase: Phase 2

Role: Collaborator

Start: Jun 9, 2021

Completion: Sep 1, 2021

NCT04831476

Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)

Phase: N/A

Role: Lead Sponsor

Start: Sep 1, 2021

Completion: Oct 31, 2022

NCT06399341

Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR).

Phase: N/A

Role: Lead Sponsor

Start: Sep 1, 2021

Completion: Apr 30, 2023

NCT05168215

Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.